Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Plos One|August 5, 2024
A cost-utility analysis of cochlear implants for single sided deafness in adults and children in the NetherlandsChris van Lieshout, Katharina Abraham, Adriana L Smit, et al.Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 15, 2022
Hospitalisation costs and health related quality of life in delirious patients: a scoping reviewChris van Lieshout, Ewoud Schuit, Carsten Hermes, et al.Pharmacoeconomics|May 1, 2016
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast CancerPieter T de Boer, Geert W J Frederix, Talitha L Feenstra, et al.Journal of Crohn'S & Colitis|October 30, 2020
Continuation of Anti-TNF in Patients With Ulcerative Colitis in Remission Is Not Cost-effective Compared With Treatment Withdrawal: A Markov ModelRemi Mahmoud, Chris van Lieshout, Geert W J Frederix, et al.Clinical Therapeutics|December 20, 2024
A Systematic Review of Challenges and Opportunities in the Implementation of Managed Entry Agreements for Advanced Therapy Medicinal ProductsAndrea Greco, Geert W J Frederix, Lotty Hooft, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 10, 2026
Adoption of Managed Entry Agreements for Advanced Therapy Medicinal Products: Semi-Structured Interviews with HTA bodies and Decision Makers in England, the Netherlands, and SpainAndrea Greco, Geert W J Frederix, Lotty Hooft, et al.Journal of Public Health Policy|March 10, 2017
Health system productivity change in Zambia: A focus on the child health servicesTom Achoki, Yohannes Kinfu, Felix Masiye, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in LiteratureRenske M T Ten Ham, Olaf H Klungel, Hubert G M Leufkens, et al.Nederlands Tijdschrift Voor Geneeskunde|June 18, 2015
[Threshold value for reimbursement of costs of new drugs: cost-effectiveness research and modelling are essential links]Geert W J Frederix, Anke M Hövels, Johan L Severens, et al.Global Spine Journal|January 29, 2021
Costs Associated With Timely and Delayed Surgical Treatment of Spinal MetastasesFloris R van Tol, Julie R A Massier, Geert W J Frederix, et al.Pageof 7